Ligand Pharmaceuticals
LGND
LGND
215 hedge funds and large institutions have $2.23B invested in Ligand Pharmaceuticals in 2015 Q2 according to their latest regulatory filings, with 50 funds opening new positions, 59 increasing their positions, 89 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
215
Holders Change
+28
Holders Change %
+14.97%
% of All Funds
5.8%
Holding in Top 10
6
Holding in Top 10 Change
-4
Holding in Top 10 Change %
-40%
% of All Funds
0.16%
New
50
Increased
59
Reduced
89
Closed
21
Calls
$23.5M
Puts
$9.55M
Net Calls
+$14M
Net Calls Change
+$14.2M
Top Buyers
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
SGK
226
Steigerwald Gordon & Koch
Leesburg,
Virginia
| – | -$328K | -16,880 | Closed |
|
|
WMSA
227
Weiss Multi-Strategy Advisers
New York
| – | -$771K | -16,030 | Closed |
|
228
Creative Planning
Overland Park,
Kansas
| – | -$699K | -14,523 | Closed |
|
|
GLA
229
Great Lakes Advisors
Chicago,
Illinois
| – | -$691K | -14,358 | Closed |
|
|
TI
230
Trexquant Investment
Stamford,
Connecticut
| – | -$547K | -11,381 | Closed |
|
|
QIM
231
Quantitative Investment Management
Charlottesville,
Virginia
| – | -$462K | -9,618 | Closed |
|
|
LCS
232
Levin Capital Strategies
New York
| – | -$363K | -7,547 | Closed |
|
|
CSS
233
Cubist Systematic Strategies
Stamford,
Connecticut
| – | -$363K | -7,539 | Closed |
|
234
SG Americas Securities
New York
| – | -$358K | -7,452 | Closed |
|
235
Nomura Holdings
Tokyo,
Japan
| – | -$326K | -6,874 | Closed |
|
236
Acadian Asset Management
Boston,
Massachusetts
| – | -$99K | -2,058 | Closed |
|